IL13 and neoplasm: Furthermore, using BM chimeric mice, we were additionally able to show that mice lacking IL-13 only in the IELs (WT→IL-13−/−) were as susceptible to DMBA carcinogenesis as mice completely lacking IL-13 and both mutants developed more tumours than WT (Fig. 4i).